More Paradigm Biopharmaceuticals Ltd. news
Paradigm Biopharmaceuticals Ltd.ASX: PAR

Completion of Institutional Entitlement Offer

Apr 23, 2019 at 11:59 PM EDT · Issued by Paradigm Biopharmaceuticals Ltd.

Filed with ASX · Apr 23, 2019 at 11:59 PM EDT

On 6ix: 6ix.com/news/completion-of-institutional-entitlement-offer-23

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Paradigm Biopharmaceuticals Ltd. on 6ix

Earlier from Paradigm Biopharmaceuticals

  • PAR Accelerated Non-Renounceable Rights Issue Offer BookletApr 16, 2019
  • Paradigm Confirms Capital Raise CommitmentsApr 16, 2019
  • Paradigm updated corporate presentationApr 14, 2019
  • Paradigm launches a$77.9M capital raiseApr 14, 2019
  • Paradigms secondary endpoints successfully metApr 14, 2019

Later from Paradigm Biopharmaceuticals

  • Quarterly Report and Appendix 4C - quarterlyApr 30, 2019
  • Paradigm Corporate Update - May 2019May 7, 2019
  • Successful Completion of Retail Entitlement OfferMay 8, 2019
  • PAR corrects afr articleMay 21, 2019
  • PAR reports consistent pain reduction in knee OA of patientsMay 27, 2019
All Paradigm Biopharmaceuticals news releases↗

Follow Paradigm Biopharmaceuticals into a list and get an email when it puts out news.

Follow Paradigm Biopharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer